Literature DB >> 4046906

The pathogenesis of Duchenne muscular dystrophy: significance of experimental observations.

J Elbrink, S K Malhotra.   

Abstract

The pathogenesis of Duchenne muscular dystrophy (DMD) remains elusive, but as this is an inherited condition the primary manifestation of the disease is assumed to be in the regulatory control or biosynthesis of a protein. Current hypotheses attribute the pathological state of skeletal muscle in DMD to a defect in the nerve supply, or in the vasculature, or in the muscle itself. However, various tissues other than skeletal muscle are also affected; thus the current view of DMD requires reevaluation. The following possibilities should be considered: That the primary lesion is expressed in one of the major communication systems (nervous, vascular, or endocrine). That the primary lesion is expressed in a specific tissue: a) if in skeletal muscle, alterations in non-muscular tissues must be due to the release of muscle constituents into extracellular fluid; b) if in a non-muscular tissue, this might produce too much (or too little or none) of a constituent normally secreted into the extracellular fluid, or produce a "toxic" agent. That the primary lesion is expressed in a wide variety of tissues: the effect on a particular tissue will depend entirely upon the degree of requirement of the altered protein for function.

Entities:  

Mesh:

Year:  1985        PMID: 4046906     DOI: 10.1016/0306-9877(85)90096-9

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Characteristics of muscle fibers reconstituted in the regeneration process of masseter muscle in an mdx mouse model of muscular dystrophy.

Authors:  Won-Hyung Lee; Shinichi Abe; Hee-Jin Kim; Akinobu Usami; Atsuro Honda; Koji Sakiyama; Yoshinobu Ide
Journal:  J Muscle Res Cell Motil       Date:  2006-06-04       Impact factor: 2.698

2.  The correlation analysis of functional factors and age with duchenne muscular dystrophy.

Authors:  Il-Young Jung; Jong Hee Chae; Sue Kyung Park; Je Ho Kim; Jung Yoon Kim; Sang Joon Kim; Moon Suk Bang
Journal:  Ann Rehabil Med       Date:  2012-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.